Interactions Between Diabetes and Anxiety and Depression Implications for Treatment

被引：26

作者：

Bystritsky, Alexander ^{[1
]}

Danial, Jessica ^{[2
]}

Kronemyer, David ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, David Geffen Sch Med, Los Angeles, CA 90095 USA

[2] Alliant Int Univ, Calif Sch Profess Psychol, Los Angeles, CA 91803 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2014年 / 43卷 / 01期

关键词：

Anxiety; Cognitive behavioral therapy; Cognitive restructuring; Depression; Diabetes; COGNITIVE-BEHAVIORAL THERAPY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT-RESISTANT DEPRESSION; ATYPICAL ANTIPSYCHOTICS; COMORBID DEPRESSION; METABOLIC SYNDROME; COLLABORATIVE CARE; GLUCOSE-METABOLISM; GLYCEMIC CONTROL; BLOOD-GLUCOSE;

D O I：

10.1016/j.ecl.2013.10.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Anxiety or depression may be a risk factor for the development of diabetes. This relationship may occur through a combination of genetic predispositions; epigenetic contingencies; exacerbating conditions such as metabolic syndrome (a precursor to diabetes); and other serious medical conditions. Medications used to treat anxiety and depression have significant side effects, such as weight gain, further increasing the possibility of developing diabetes. These components combine, interact, and reassemble to create a precarious system for persons with, or predisposed to, diabetes. Clinicians must be aware of these interrelationships to adequately treat the disease.

引用

页码：269 / +

页数：16

共 108 条

[1] The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies [J].